CTMX vs. ERIC
CTMX (CytomX Therapeutics, Inc.) and ERIC (Telefonaktiebolaget LM Ericsson (publ)) are both stocks. CTMX operates in Biotechnology (Healthcare), while ERIC operates in Communication Equipment (Technology). Over the past 10 years, CTMX returned -10.76%/yr vs 7.09%/yr for ERIC. At a 0.23 correlation, their price movements are largely independent.
Performance
CTMX vs. ERIC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CTMX achieves a -26.06% return, which is significantly lower than ERIC's 19.61% return. Over the past 10 years, CTMX has underperformed ERIC with an annualized return of -10.76%, while ERIC has yielded a comparatively higher 7.09% annualized return.
CTMX
- 1D
- 3.62%
- 1M
- -16.22%
- YTD
- -26.06%
- 6M
- -25.00%
- 1Y
- 45.83%
- 3Y*
- 26.94%
- 5Y*
- -14.01%
- 10Y*
- -10.76%
ERIC
- 1D
- -2.90%
- 1M
- -15.70%
- YTD
- 19.61%
- 6M
- 19.24%
- 1Y
- 43.07%
- 3Y*
- 36.45%
- 5Y*
- 1.73%
- 10Y*
- 7.09%
CTMX vs. ERIC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CTMX CytomX Therapeutics, Inc. | -26.06% | 313.59% | -33.55% | -3.13% | -63.05% | -33.89% | -21.18% | -44.97% | -28.47% | 92.08% |
ERIC Telefonaktiebolaget LM Ericsson (publ) | 19.61% | 24.14% | 33.36% | 13.40% | -44.43% | -7.26% | 38.51% | 0.17% | 35.45% | 16.57% |
Correlation
The correlation between CTMX and ERIC is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since Oct 8, 2015 | 0.23 |
The correlation between CTMX and ERIC shifts across timeframes, from 0.12 (1 year) to 0.23 (all time), reflecting how their relationship changes across market environments.
Fundamentals
CTMX:
$558.41M
ERIC:
$38.04B
CTMX:
-$0.37
ERIC:
SEK 7.42
CTMX:
14.21
ERIC:
1.59
CTMX:
1.75
ERIC:
3.60
CTMX:
$35.54M
ERIC:
SEK 229.49B
CTMX:
$24.77M
ERIC:
SEK 110.27B
CTMX:
-$62.07M
ERIC:
SEK 46.17B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CTMX vs. ERIC — Risk / Return Rank
CTMX
ERIC
CTMX vs. ERIC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for CytomX Therapeutics, Inc. (CTMX) and Telefonaktiebolaget LM Ericsson (publ) (ERIC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CTMX | ERIC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.69 | ||
| Sortino ratioReturn per unit of downside risk | -0.49 | ||
| Omega ratioGain probability vs. loss probability | 1.19 | 1.27 | -0.08 |
| Calmar ratioReturn relative to maximum drawdown | 0.81 | 2.52 | -1.71 |
| Martin ratioReturn relative to average drawdown | 1.89 | 6.35 | -4.46 |
Loading charts...
Drawdowns
CTMX vs. ERIC - Drawdown Comparison
The maximum CTMX drawdown since its inception was -98.74%, roughly equal to the maximum ERIC drawdown of -98.59%. Use the drawdown chart below to compare losses from any high point for CTMX and ERIC.
Loading charts...
Drawdown Indicators
| CTMX | ERIC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.74% | -98.59% | -0.15% |
Max Drawdown (1Y)Largest decline over 1 year | -56.89% | -17.18% | -39.71% |
Max Drawdown (3Y)Largest decline over 3 years | -91.59% | -22.61% | -68.98% |
Max Drawdown (5Y)Largest decline over 5 years | -94.16% | -63.96% | -30.20% |
Max Drawdown (10Y)Largest decline over 10 years | -98.74% | -66.59% | -32.15% |
Current DrawdownCurrent decline from peak | -90.79% | -83.80% | -6.99% |
Average DrawdownAverage peak-to-trough decline | -70.94% | -67.78% | -3.16% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.26% | 6.80% | +17.46% |
Volatility
CTMX vs. ERIC - Volatility Comparison
CytomX Therapeutics, Inc. (CTMX) and Telefonaktiebolaget LM Ericsson (publ) (ERIC) have volatilities of 14.67% and 14.61%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CTMX | ERIC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.67% | 14.61% | +0.06% |
Volatility (6M)Calculated over the trailing 6-month period | 67.16% | 25.52% | +41.64% |
Volatility (1Y)Calculated over the trailing 1-year period | 93.70% | 36.73% | +56.97% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 141.88% | 34.72% | +107.16% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 111.37% | 35.21% | +76.16% |
Dividends
CTMX vs. ERIC - Dividend Comparison
CTMX has not paid dividends to shareholders, while ERIC's dividend yield for the trailing twelve months is around 2.75%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CTMX CytomX Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ERIC Telefonaktiebolaget LM Ericsson (publ) | 2.75% | 3.04% | 3.22% | 4.07% | 4.22% | 2.15% | 1.36% | 1.24% | 1.42% | 1.67% | 5.14% | 5.30% |
Financials
CTMX vs. ERIC - Financials Comparison
This section allows you to compare key financial metrics between CytomX Therapeutics, Inc. and Telefonaktiebolaget LM Ericsson (publ). You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CTMX and ERIC have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CTMX has higher volatility (14.67%) compared to ERIC (14.61%). In terms of maximum drawdown, CTMX dropped -98.74% vs ERIC's -98.59%.
ERIC currently has the higher Sharpe Ratio (1.18 vs 0.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CTMX and ERIC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer